These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10880093)
1. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. Jin QM; Takita H; Kohgo T; Atsumi K; Itoh H; Kuboki Y J Biomed Mater Res; 2000 Sep; 51(3):491-9. PubMed ID: 10880093 [TBL] [Abstract][Full Text] [Related]
2. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. Jin QM; Takita H; Kohgo T; Atsumi K; Itoh H; Kuboki Y J Biomed Mater Res; 2000 Dec; 52(4):491-9. PubMed ID: 11033569 [No Abstract] [Full Text] [Related]
3. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. Kuboki Y; Jin Q; Takita H J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S105-15. PubMed ID: 11314788 [TBL] [Abstract][Full Text] [Related]
4. Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Kuboki Y; Jin Q; Kikuchi M; Mamood J; Takita H Connect Tissue Res; 2002; 43(2-3):529-34. PubMed ID: 12489210 [TBL] [Abstract][Full Text] [Related]
5. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. Ono I; Yamashita T; Jin HY; Ito Y; Hamada H; Akasaka Y; Nakasu M; Ogawa T; Jimbow K Biomaterials; 2004 Aug; 25(19):4709-18. PubMed ID: 15120517 [TBL] [Abstract][Full Text] [Related]
6. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268 [TBL] [Abstract][Full Text] [Related]
7. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. Kuboki Y; Takita H; Kobayashi D; Tsuruga E; Inoue M; Murata M; Nagai N; Dohi Y; Ohgushi H J Biomed Mater Res; 1998 Feb; 39(2):190-9. PubMed ID: 9457547 [TBL] [Abstract][Full Text] [Related]
8. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice. Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650 [TBL] [Abstract][Full Text] [Related]
9. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic. Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262 [TBL] [Abstract][Full Text] [Related]
10. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Takahashi Y; Yamamoto M; Tabata Y Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265 [TBL] [Abstract][Full Text] [Related]
11. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation. Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458 [TBL] [Abstract][Full Text] [Related]
12. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Ripamonti U; Crooks J; Khoali L; Roden L Biomaterials; 2009 Mar; 30(7):1428-39. PubMed ID: 19081131 [TBL] [Abstract][Full Text] [Related]
13. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252 [TBL] [Abstract][Full Text] [Related]
14. Localization of bone morphogenetic protein-induced bone and cartilage formation on a new carrier: fibrous collagen membrane. Shigenobu K; Kaneda K; Nagai N; Kuboki Y Ann Chir Gynaecol Suppl; 1993; 207():85-90. PubMed ID: 8154842 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678 [TBL] [Abstract][Full Text] [Related]
16. BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Tazaki J; Murata M; Akazawa T; Yamamoto M; Ito K; Arisue M; Shibata T; Tabata Y Biomed Mater Eng; 2009; 19(2-3):141-6. PubMed ID: 19581707 [TBL] [Abstract][Full Text] [Related]
17. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. Tsuruga E; Takita H; Itoh H; Wakisaka Y; Kuboki Y J Biochem; 1997 Feb; 121(2):317-24. PubMed ID: 9089406 [TBL] [Abstract][Full Text] [Related]
18. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation. Liu HW; Chen CH; Tsai CL; Hsiue GH Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421 [TBL] [Abstract][Full Text] [Related]
19. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Na K; Kim SW; Sun BK; Woo DG; Yang HN; Chung HM; Park KH Biomaterials; 2007 Jun; 28(16):2631-7. PubMed ID: 17331575 [TBL] [Abstract][Full Text] [Related]
20. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo. Yoshikawa T; Nakajima H; Yamada E; Akahane M; Dohi Y; Ohgushi H; Tamai S; Ichijima K J Bone Miner Res; 2000 Jun; 15(6):1147-57. PubMed ID: 10841184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]